References
- Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, . The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284: 1835–7.
- Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275–306.
- Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:305–10.
- Fonteneau JF, Larsson M, Beignon AS, McKenna K, Dasilva I, Amara A, . Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol. 2004;78:5223–32.
- Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Munz C, Liu YJ, . Activation of influenza virus-specific CD4 + and CD8 + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood. 2003;101:3520–6.
- Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, . Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 2007;27:481–92.
- Bauer J. Advances in cell separation: recent developments in counterflow centrifugal elutriation and continuous flow cell separation. J Chromatogr B Biomed Sci Appl. 1999;722: 55–69.
- Wahl LM, Wahl SM, Smythies LE, Smith PD. Isolation of human monocyte populations. Curr Protoc Immunol. 2006;Chapter 7:Unit 7 6A.
- Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, . Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods. 2005;298:61–72.
- Powell DJ Jr, Brennan AL, Zheng Z, Huynh H, Cotte J, Levine BL. Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program. Cytotherapy. 2009;11:923–35.
- Micklethwaite KP, Garvin FM, Kariotis MR, Yee LL, Hansen AM, Antonenas V, . Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity. Cytotherapy. 2009;11:218–28.
- Eifler RL, Lind J, Falkenhagen D, Weber V, Fischer MB, Zeillinger R. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept. Cytometry B Clin Cytom. 2011;80:100–11.
- Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669–92.
- ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ, Vrielink H, Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation. Immunobiology. 2006; 211:633–40.
- Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, . Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med. 2006;203:1999–2008.
- Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, . BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037–46.
- Gerrits JH, Athanassopoulos P, Vaessen LM, Klepper M, Weimar W, van Besouw NM. Peripheral blood manipulation significantly affects the result of dendritic cell monitoring. Transpl Immunol. 2007;17:169–77.